A microemulsion of puerarin–phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations

Reference

• Wang N, Zhang Y, Wu L, et al. Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. Neuropharmacology. 2014;79:282–289.
   PubMed Web of Science ®Google Scholar
• Wu X-D, Wang C, Zhang Z-Y, et al. Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats. Evid-Based Complement Alternat Med. 2014;2014:408501.
   PubMedGoogle Scholar
• Tan C, Wang A, Liu C, et al. Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension. Am J Chin Med. 2017;45:1169–1184.
   PubMed Web of Science ®Google Scholar
• Wang S, Shi X-L, Feng M, et al. Puerarin protects against CCl 4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. Int Immunopharmacol. 2016;38:238–245.
   PubMed Web of Science ®Google Scholar
• Xu L, Zheng N, He Q, et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. Phytomedicine. 2013;20:1172–1179.
   PubMed Web of Science ®Google Scholar
• Hu Y-X, Yu C-H, Wu F, et al. Antihepatofibrotic effects of aqueous extract of prunella vulgaris on carbon tetrachloride-induced hepatic fibrosis in rats. Planta Medica. 2016;82:97–105.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang Q, Shao S, et al. Lyophilized powder of catalpol and puerarin protected cerebral vessels from ischemia by its anti-apoptosis on endothelial cells. Int J Biol Sci. 2017;13:327.
   PubMed Web of Science ®Google Scholar
• Li Z, Shangguan Z, Liu Y, et al. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway. J Mol Endocrinol. 2014;53:71–79.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Zhang X, Cai X, et al. Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. PLoS One. 2014;9:e85690.
   PubMed Web of Science ®Google Scholar
• Wang J-W, Wang H-D, Cong Z-X, et al. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J Surg Res. 2014;186:328–337.
   PubMed Web of Science ®Google Scholar
• Mahdy HM, Mohamed MR, Emam MA, et al. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. Can J Physiol Pharmacol. 2014;92:252–258.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang Y, Liu J, et al. Protective effects of genistein and puerarin against chronic alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. J Agric Food Chem. 2016;64:7291–7297.
   PubMed Web of Science ®Google Scholar
• Liu R, Xing D, Lu H, et al. Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats. Am J Chin Med. 2006;34:1037–1045.
   PubMed Web of Science ®Google Scholar
• Luo C-F, Yuan M, Chen M-S, et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharma. 2011;410:138–144.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang DJ, Chen SL, et al. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation. Int J Pharma. 2008;359:35–45.
   PubMed Web of Science ®Google Scholar
• Liu X, Ding Y, Zhao B, et al. In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles. Drug Dev Indust Pharm. 2016;42:2031–2037.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Advanced Drug Delivery Reviews. 2012;64:175–193.
   Web of Science ®Google Scholar
• Xu M, Yu Q, Zhao Q, et al. Development and in vitro–in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin. Drug Dev Indust Pharm. 2016;42:280–287.
   PubMed Web of Science ®Google Scholar
• L Shinde R, B Jindal A, V Devarajan P. Microemulsions and nanoemulsions for targeted drug delivery to the brain. Cnano. 2011;7:119–133.
   Google Scholar
• Tang T-T, Hu X-B, Liao D-H, et al. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. Int J Nanomed. 2013;8:4415.
   PubMed Web of Science ®Google Scholar
• Bombardelli E, Cristoni A, Morazzoni P. Phytosomes in functional cosmetics. Fitoterapia. 1994;65:387–401.
   Google Scholar
• Yu F, Li Y, Chen Q, et al. Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. Eur J Pharma Biopharm. 2016;103:136–148.
   PubMed Web of Science ®Google Scholar
• Ge L, He X, Zhang Y, et al. A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract. Nanomed: Nanotechnol, Biol Med. 2017. DOI:10.1016/j.nano.2017.08.009
   Google Scholar
• Cui F, Shi K, Zhang L, et al. Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Controlled Release. 2006;114:242–250.
   PubMed Web of Science ®Google Scholar
• Dahan A, West BT, Amidon GL. Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Eur J Pharma Sci. 2009;36:320–329.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Haltner E, Lehr C-M, et al. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int J Pharm. 2000;211:29–36.
   PubMed Web of Science ®Google Scholar
• Karamustafa F, Celebi N. Development of an oral microemulsion formulation of alendronate: Effects of oil and co-surfactant type on phase behaviour. J Microencapsul. 2008; 25:315–323.
   PubMed Web of Science ®Google Scholar
• Čilek A, Čelebi N, Tirnaksiz F. Lecithin-based microemulsion of a peptide for oral administration: preparation, characterization, and physical stability of the formulation. Drug Deliv. 2006;13:19–24.
   PubMed Web of Science ®Google Scholar
• Kim JE, Yoon IS, Cho HJ, et al. Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity. Int J Pharma. 2014;464:117–126.
   PubMed Web of Science ®Google Scholar
• Cheng MB, Wang JC, Li YH, et al. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. J Control Release. 2008;129:41–48.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Horowitz AT, et al. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev. 2004;56:1177–1192.
   PubMed Web of Science ®Google Scholar
• Sachs-Barrable K, Lee SD, Wasan EK, et al. Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections. Adv Drug Deliv Rev. 2008;60:692–701.
   PubMed Web of Science ®Google Scholar
• Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59:667–676.
   PubMed Web of Science ®Google Scholar